webinar recording available - register to watch

Lessons from the Real World: Journey from Claims to EHR Data in Real-World Evidence Generation

Medical and pharmacy claims data have been the industry go-to for real-world data (RWD) and real-world evidence generation (RWE). But claims data is missing essential information such as patient outcomes, clinical nuance, diagnoses that don’t have an ICD-9/10 code, and brands of treatments that share a code. Much of this crucial data lies in unstructured clinical notes within electronic health records (EHRs), which are becoming a growing source of quality RWD across life sciences. The most powerful option is often to combine claims and EHR sources. This webinar will examine the evolution of RWD sources, explore claims vs. EHR data, and provide key examples of how companies are leveraging each source to drive decision-making.

In this webinar, experts from Genentech and Verana Health will:
  • Analyze specific elements that can be utilized in claims vs. EHR data as RWD sources, both individually and when linked
  • Review how advanced AI is applied to curate EHR clinical notes and extract key information at scale
  • Offer examples and case studies of how life sciences companies select and then leverage these data sources for RWE studies
watch now
watch the webinar

No cost to register, subject to confirmation

By registering for this event, you accept that you may receive direct communication from the sponsor(s).

If you are experiencing problems with your registration, please try the Zoom registration page.

Dawn Sim

Dawn Sim

Medical Director of Ophthalmology, Genentech

Dawn Sim is currently Medical Director of Ophthalmology at Genentech and has been working on the Vabysmo and Port Delivery system teams since 2022. Since 2008, she trained and worked in London, UK as a Consultant Ophthalmic Surgeon, Retinal Specialist Director of Telemedicine, and Associated Professor at Moorfields Eye Hospital and University College London where she obtained her PhD in neurobiology.

Aracelis Torres

Aracelis Torres

Senior Vice President of Data & Science, Verana Health

Aracelis Torres, PhD, MPH, is Senior Vice President of Data Science, where she oversees the Quantitative Sciences team working on rigorous methodology to generate sound scientific evidence from real-world data, as well as the commercial services and operations team that manage client deliverables. Dr. Torres is an epidemiologist with over ten years of academic and industry experience. Prior to joining Verana Health, she was a Director of Quantitative Sciences at Flatiron Health, where her work focused on translation of real-world oncology data to generate evidence. While at Flatiron Health, she led efforts related to the development of real- world endpoints, novel study designs, and prospective evidence generation while also serving as the Quantitative Sciences lead for the organization’s broader research collaboration with the FDA. She is also currently an Adjunct Professor at Columbia University Graduate School of Arts and Sciences, where she teaches a course on large-scale data processing and analysis. Dr. Torres received a PhD in Cancer Epidemiology from Johns Hopkins Bloomberg School of Public Health, an MPH in Chronic Disease Epidemiology from Yale University’s School of Public Health, and a BS in Molecular, Cellular, and Developmental Biology from Yale University.

Sy Mukherjee
moderator

Sy Mukherjee

Freelance healthcare journalist

Sy Mukherjee is a veteran healthcare journalist who has been covering the space with a focus on biopharma, drug development, digital health, and the intersection of medicine and technology across the health industry for more than a decade. He has served roles as: the first editor of the industry trade publication BioPharma Dive; a biopharma/digital health/healthcare-specialized reporter at Fortune Magazine for nearly six years, where he authored a biopharma/digital health newsletter, wrote articles for Fortune.com, and reported for the print magazine issue (including two cover stories focused on the digital health revolution and the intersection of data, biology, and health systems), and helped plan, cover, and moderate events at the annual Brainstorm Health conference. Additionally, he served as a consultant at the boutique path-to-market strategy life sciences consultancy IDEA Pharma, focusing on stakeholder-oriented strategic communications for biotech and pharma clients.

Sy has extensive experience moderating webinars and panels at both small and high-profile venues, including panels at Fortune Brainstorm Health and the Biden Cancer Summit. He is currently an independent and freelance journalist still focused on the same space that he's covered for his entire career.